Australia markets open in 8 hours 44 minutes

CSR Limited (CSR.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
8.81+0.01 (+0.11%)
At close: 04:10PM AEDT
Full screen
Previous close8.80
Bid8.81 x 298600
Ask8.82 x 1072800
Day's range8.79 - 8.83
52-week range4.63 - 8.84
Avg. volume2,419,712
Market cap4.206B
Beta (5Y monthly)0.80
PE ratio (TTM)12.96
EPS (TTM)0.68
Earnings date08 May 2024 - 13 May 2024
Forward dividend & yield0.35 (3.97%)
Ex-dividend date07 Nov 2023
1y target est6.97
  • Bloomberg

    Saint-Gobain Offers to Buy Rival CSR in $2.8 Billion Deal

    (Bloomberg) -- Cie. de Saint-Gobain of France offered to buy Australia’s CSR Ltd. for A$4.3 billion ($2.8 billion) as the building industry consolidates amid a shift to more climate-friendly materials.Most Read from BloombergNvidia Surges After Company Proclaims AI Has Hit 'Tipping Point'Biden Touts $1.2 Billion in Student Loan Relief With Eye to 2024Tech Up in Late Hours on Nvidia’s Bullish Outlook: Markets WrapChina Tightens Grip on Stocks With Net Sale Ban at Open, CloseYour 401(k) Will Be Go

  • Reuters

    Australia's CSR stock rises after $2.8 billion takeover offer from Saint-Gobain

    (Reuters) -Australia's CSR Ltd shares rose a further 5% on Thursday as the building products maker came into play following a A$4.30 billion ($2.81 billion) non-binding takeover proposal from France's Saint-Gobain . The Sydney-based firm said it had received a A$9.0 per share offer from the French group, which represented a premium of 13.2% to CSR's last close. CSR is one of Australia's oldest companies, having been established in 1855, initially as a sugar refining business, before its diversification into building products.

  • Bloomberg

    Saint Gobain Considers Buying Australian Rival CSR

    (Bloomberg) -- French building materials producer Cie. de Saint-Gobain is exploring a potential acquisition of CSR Ltd., people familiar with the matter said, sending shares of the Australian company up the most in nearly 32 years. Most Read from BloombergYour 401(k) Will Be Gone Within a DecadeLargest Covid Vaccine Study Yet Finds Links to Health ConditionsCapital One to Buy Discover for $35 Billion in Top 2024 DealChina Tightens Grip on Stocks With Net Sale Ban at Open, CloseUS Tells Allies Ru